Multi-spectroscopic investigation, molecular docking and molecular dynamic simulation of competitive interactions between flavonoids (quercetin and rutin) and sorafenib for … NA Alsaif, TA Wani, AH Bakheit, S Zargar International Journal of Biological Macromolecules 165, 2451-2461, 2020 | 95 | 2020 |
Interaction of an abiraterone with calf thymus DNA: Investigation with spectroscopic technique and modelling studies TA Wani, N Alsaif, AH Bakheit, S Zargar, AA Al-Mehizia, AA Khan Bioorganic Chemistry 100, 103957, 2020 | 81 | 2020 |
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis NA Alsaif, MA Dahab, MM Alanazi, AJ Obaidullah, AA Al-Mehizia, ... Bioorganic Chemistry 110, 104807, 2021 | 77 | 2021 |
New bis ([1, 2, 4] triazolo)[4, 3-a: 3′, 4′-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer … MM Alanazi, HA Mahdy, NA Alsaif, AJ Obaidullah, HM Alkahtani, ... Bioorganic Chemistry 112, 104949, 2021 | 72 | 2021 |
Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers MM Alanazi, IH Eissa, NA Alsaif, AJ Obaidullah, WA Alanazi, AF Alasmari, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1760-1782, 2021 | 70 | 2021 |
Design and discovery of new antiproliferative 1, 2, 4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site IH Eissa, MA Dahab, MK Ibrahim, NA Alsaif, AZ Alanazi, SI Eissa, ... Bioorganic Chemistry 112, 104965, 2021 | 55 | 2021 |
A potential anticancer dihydropyrimidine derivative and its protein binding mechanism by multispectroscopic, molecular docking and molecular dynamic simulation along with its … TA Wani, N Alsaif, MM Alanazi, AH Bakheit, S Zargar, MA Bhat European Journal of Pharmaceutical Sciences 158, 105686, 2021 | 55 | 2021 |
New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah, HM Alkahtani, ... RSC advances 11 (48), 30315-30328, 2021 | 55 | 2021 |
Binding of colchicine and ascorbic acid (vitamin C) to bovine serum albumin: An in-vitro interaction study using multispectroscopic, molecular docking and molecular dynamics … TA Wani, NA Alsaif, MM Alanazi, AH Bakheit, AA Khan, S Zargar Journal of Molecular Liquids 342, 117542, 2021 | 50 | 2021 |
Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers NA Alsaif, MS Taghour, MM Alanazi, AJ Obaidullah, AA Al-Mehizia, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 1093-1114, 2021 | 46 | 2021 |
A comprehensive investigation of interactions between antipsychotic drug quetiapine and human serum albumin using multi-spectroscopic, biochemical, and molecular modeling … S Zargar, TA Wani, NA Alsaif, AIA Khayyat Molecules 27 (8), 2589, 2022 | 45 | 2022 |
A spectroscopic, thermodynamic and molecular docking study of the binding mechanism of dapoxetine with calf thymus DNA NA Alsaif, AA Al-Mehiziaa, AH Bakheit, S Zargar, TA Wani South African Journal of Chemistry 73 (1), 44–50-44–50, 2020 | 45 | 2020 |
Synthesis of benzensulfonamides linked to quinazoline scaffolds as novel carbonic anhydrase inhibitors AS El-Azab, AM Alaa, S Bua, A Nocentini, MA El-Gendy, MA Mohamed, ... Bioorganic Chemistry 87, 78-90, 2019 | 45 | 2019 |
Pomegranate peel induced biogenic synthesis of silver nanoparticles and their multifaceted potential against intracellular pathogen and cancer AA Khan, AM Alanazi, N Alsaif, TA Wani, MA Bhat Saudi Journal of Biological Sciences 28 (8), 4191-4200, 2021 | 43 | 2021 |
Mechanistic interaction study of 5, 6-Dichloro-2-[2-(pyridin-2-yl) ethyl] isoindoline-1, 3-dione with bovine serum albumin by spectroscopic and molecular docking approaches MM Alanazi, AA Almehizia, AH Bakheit, NA Alsaif, HM Alkahtani, TA Wani Saudi Pharmaceutical Journal 27 (3), 341-347, 2019 | 43 | 2019 |
Interaction characterization of a tyrosine kinase inhibitor erlotinib with a model transport protein in the presence of quercetin: A drug–protein and drug–drug interaction … TA Wani, MM Alanazi, NA Alsaif, AH Bakheit, S Zargar, OM Alsalami, ... Molecules 27 (4), 1265, 2022 | 41 | 2022 |
Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies MM Alanazi, A Elwan, NA Alsaif, AJ Obaidullah, HM Alkahtani, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1732-1750, 2021 | 40 | 2021 |
Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study MM Alanazi, H Elkady, NA Alsaif, AJ Obaidullah, WA Alanazi, ... Journal of Molecular Structure 1253, 132220, 2022 | 39 | 2022 |
Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2 AJ Obaidullah, MM Alanazi, NA Alsaif, H Albassam, AA Almehizia, ... RSC advances 11 (29), 18103-18121, 2021 | 39 | 2021 |
Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives AM Alaa, AS El-Azab, S Bua, A Nocentini, MAA El-Enin, MM Alanazi, ... Bioorganic chemistry 87, 425-431, 2019 | 37 | 2019 |